mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
6e-06 |
mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0008 |
mRNA |
THZ-2-49 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.003 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.004 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
Ispinesib Mesylate |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.005 |